Synapse - Robert Maki

Results (241)

Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with fluorouracil in patients with advanced solid tumors

Journal Article

Kortmansky, J.; Shah, M. A.; Kaubisch, A.; Weyerbacher, A.; Yi, S.; Tong, W.; Sowers, R.; Gonen, M.; O'reilly, E.; Kemeny, N.; more...
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

A 14-year retrospective review of angiosarcoma: Clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy

Journal Article

Fury, M. G.; Antonescu, C. R.; Van Zee, K. J.; Brennan, M. F.; Maki, R. G.
The Cancer Journal (2005)

Fulltext@MSK | Save

Bluish papule in a middle-aged man

Journal Article

Dubroff, R. P.; Maki, R. G.; Busam, K. J.; Sachs, D. L.
Archives of Dermatology (2005)

Fulltext@MSK | Save

Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas

Journal Article

D'adamo, D. R.; Anderson, S. E.; Albritton, K.; Yamada, J.; Riedel, E.; Scheu, K.; Schwartz, G. K.; Chen, H.; Maki, R. G.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation

Journal Article

Antonescu, C. R.; Besmer, P.; Guo, T.; Arkun, K.; Hom, G.; Korytowsky, B.; Leversha, M. A.; Jeffrey, P. D.; Desantis, D.; Singer, S.; more...
Clinical Cancer Research (2005)

Fulltext@MSK | Save

Correlation between the pattern of DNA repair efficiency and the natural history of patients with advanced sarcoma treated with ET-743 (Yondelis)

Meeting Abstract

van Oosterom, A.; Maki, R.; Taron, M.; Sciot, R.; Sousa-Faro, J. M. F.; Nieto, A.; Jimeno, J.; Rosell, R.
Annals of Oncology (2004)

Fulltext@MSK | Save

Activity of gemcitabine plus docetaxel in leiomyosarcoma (LMS) and other histologies: Report of an expanded phase II trial

Meeting Abstract

Hensley, M. L.; Anderson, S.; Soslow, R.; Antonescu, C.; Upham, T.; Riedel, E.; Aghajanian, C.; Maki, R. G.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Impact of ifosfamide-based chemotherapy on survival in patients with primary extremity synovial sarcoma

Meeting Abstract

Eilber, F. C.; Eilber, F. R.; Eckardt, J. J.; Rosen, G.; Forscher, C.; Maki, R. G.; Grobmyer, S. R.; Brennan, M. F.; Singer, S.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

SU11248, a multi-targeted tyrosine kinase inhibitor, can overcome imatinib (IM) resistance caused by diverse genomic mechanisms in patients (pts) with metastatic gastrointestinal stromal tumor (GIST)

Meeting Abstract

Demetri, G. D.; Desai, J.; Fletcher, J. A.; Morgan, J. A.; Fletcher, C. D. M.; Kazanovicz, A.; Van Den Abbeele, A.; Baum, C.; Maki, R.; Heinrich, M. C.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Cardiac toxicity in a phase II study of doxorubicin (DOX) and bevacizumab (BEV) for patients (pts) with metastatic soft-tissue sarcomas

Meeting Abstract

D'adamo, D. R.; Anderson, S.; Albritton, K.; Yamada, J.; Riedel, E.; Scheu, K.; Schwartz, G. K.; Chen, H.; Maki, R. G.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save